Prevent Duplicate Subjects
Home
VCT offers optional biometric fingerprint research subject verification technology that is like no other in the industry to detect professional research subjects in clinical trials. Cutting edge fingerprint verification eliminates issues with fake IDs to detect and prevent professional research subjects at the time of screening. The fingerprint verification improves accuracy and speed reducing transcription errors. VCT never actually collects or stores the actual fingerprint but creates a proprietary reproducible template that is encrypted as well. Easy and cost effective to setup. VCT’s biometric solutions comply with local privacy regulations and can be used around the globe to detect and prevent professional research subjects and duplicate research subjects from entering your clinical trials to improve overall safety and data quality.
VCT’s optional facial recognition biometrics can be used for decentralized or virtual clinical trials or can be employed in traditional clinical trials at the research site. Biometric solutions increase speed and accuracy to make VCT the most advanced solution in the quest for optimal research subject selection to detect and prevent professional research subjects in clinical trials.
VCT’s biometric solutions eliminate issues with fake IDs and help select a better qualified subject for your trial. VCT has developed a mobile application platform that allows for fast and easy verifications even as the industry moves towards decentralized and virtual studies. VCT’s facial recognition platform can be utilized on any mobile device or tablet as well as a computer.
VCT’s biometric solutions comply with local privacy regulations and can be used around the globe to detect and prevent professional research subjects and duplicate research subjects from entering your clinical trials to improve overall safety and data quality.
VCT is the world’s expert and leader when it comes to CNS and psychiatry clinical trials. Verified Clinical Trials is proud to state that the majority of sponsors conducting clinical trials in CNS and psychiatry utilize the Verified Clinical Trials global registry to detect and prevent duplicate subjects and professional research subjects around the world. VCT boasts the largest CNS and psychiatry clinical trials research subject database registry both in the United States and rest of world. The registry spans across the United States and 50 countries worldwide. There is no other company or system like Verified Clinical Trials.
Verified Clinical Trials has a proprietary system in place that has allowed the registry to operate in more than 50 countries around the globe. VCT continues to work with numerous ethics committees and regulators so that it may bring improved safety and data quality to the sponsors that conduct clinical trials around the world. No country or region is immune to the potential protocol violations such as duplicate enrollment and others. VCT’s global coverage includes phase I and phase II and phase III studies across multiple therapeutic indications. Detecting duplicate research subjects, or professional research subjects in clinical trials at the time of screening and continuing the protections then entire duration of the trial.
Imagine that upwards of 10% or more of your research participants are providing fake answers to the study coordinator. Study subjects that are untruthful about their concurrent participation in another drug trial are far more likely to report inaccurate efficacy results. Professional subjects may report efficacy simply to legitimize their participation for site staff. This false efficacy reporting is detrimental to the active comparator efficacy results and will raise placebo rates. Alternatively, if a research subject is participating in the same study at multiple sites because they fear they may be on placebo or low dose, they may be receiving too large a dose that may result in adverse events. Furthermore, we witness research subjects moving between various clinical trials across different therapeutic indications again ingesting investigational products with unknown interactions with other investigational products. This ultimately affects efficacy rates, placebo rates, and the incidence of adverse events. These issues can result in a clinical trials failure. By using the Verified Clinical Trials research subject database registry to prevent duplicate subjects and professional subjects, you can mitigate these issues.
